George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Innov Regulatory News (SEED)

Share Price Information for Seed Innov (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.05
Bid: 2.00
Ask: 2.10
Change: -0.05 (-2.38%)
Spread: 0.10 (5.00%)
Open: 2.10
High: 2.10
Low: 2.05
Prev. Close: 2.10
SEED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Investment in Leap Gaming

22 Nov 2021 07:00

RNS Number : 0922T
Seed Innovations Limited
22 November 2021
 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

22 November 2021

SEED Innovations Ltd ("SEED" or, the "Company")

 

Further Investment in Leap Gaming

 

SEED Innovations Limited, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to announce that it has invested a further €450,000 (the 'Investment') in Fralis LLC, trading as Leap Gaming ('Leap'), an Israel based B2B developer of high-end 3D gaming applications whose games are offered by leading online and retail gaming operators worldwide. 

 

The Investment, funded from existing Company cash resources, is by way of an extension to the existing €1million 1% Convertible Loan Note ('CLN') as part of a funding round by Leap to raise up to a further €1.2million. The Investment takes the total amount invested by SEED in Leap convertible loan notes to €741,641 (c.£630,000 based on approximate GBP cost prices on the investment dates). The Company also holds 47.06% of the total equity of Leap (on an un-diluted basis).

 

Highlights

Investment is alongside further investment from existing Leap shareholder, IMG Arena, a subsidiary of Endeavour Group (NYSE: EDR)

Attractive conversion terms, with a conversion ceiling below SEEDs 31 March 2021 valuation of 100% of Leap of €23.95million

Progress being made at Leap with forecast metrics for year to 31 December 2021:

o Turnover: Up 40% compared to December 2020;

o Transactions: Up 60% on prior year; and

o Daily Average Users: Up 60%

Minimum fees from operators at September 2021 double that of 2020

 

Ed McDermott, CEO of SEED, commented: "This investment reflects our ongoing support of Leap Gaming and their team as they continue to challenge the gaming industry worldwide. The funding will further facilitate their development and movement towards a possible liquidity event with all options, including M&A activity and a near term public market offering, being contemplated. Although not a sector of core focus for SEED, this long-term investment that we have supported for some time is an important contributor to our net asset value, and with the growth Leap has seen and is forecasting to year end, we anticipate positive news flow and corporate development into 2022."

 

Principal Terms of the Convertible Loan Note

The CLN will automatically convert as follows:

· Immediately prior to an equity financing (of more than €1million) or liquidity event of Leap at the lower of a 25% discount to the lowest issue price per share at that event or a pre-money valuation of €15million (in line with the previous convertible loans since June 2020, of which this investment forms a part); or

· At maturity (31 December 2022) at the price per share of the last equity financing round of Leap (being €3,265.31 per share in June 2018, see RNS of 12 June 2018).

 

Interest shall accrue on the CLN at a rate of 1% per annum and will be aggregated with principal at conversion.

 

This CLN will not qualify as a qualifying fundraise under the terms of the Company's previous convertible loan investment in February 2021.

 

About Leap Gaming

Leap is a developer of high-end virtual-sports, slots, and casino applications serving hundreds of gaming brands and generating tens of thousands of engagement points with end-users. Leap's attention to detail in its solutions and services is manifested in the modular engagement terms it offers to its operating partners and its ability to provide seamless experiences across mobile, desktop and retail environments. Leap is licensed by the MGA and certified for other jurisdictions worldwide.

 

ENDS

 

For further information on the Company please visit www.seedinnovations.co or contact:

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Catherine Leftley

Isabelle Morris

St Brides Partners Ltd,

Financial PR

E: info@stbridespartners.co.uk

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFELSIEEFSELF
Date   Source Headline
26th Apr 20244:46 pmRNSTransaction in Own Shares
25th Apr 202411:03 amRNSTransaction in Own Shares
24th Apr 20243:14 pmRNSTransaction in Own Shares & TVR
23rd Apr 202411:11 amRNSTransaction in Own Shares
22nd Apr 202411:33 amRNSTransaction in Own Shares
19th Apr 202410:55 amRNSTransaction in Own Shares & TVR
18th Apr 20241:20 pmRNSTransaction in Own Shares
17th Apr 20242:57 pmRNSInvestee Company Update: Little Green Pharma Ltd
17th Apr 202411:55 amRNSTransaction in Own Shares & TVR
16th Apr 20247:00 amRNSSpecial Dividend Declaration
15th Apr 20243:20 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSReceipt of remaining £2.4m from sale of Leap
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares & TVR
9th Apr 20241:00 pmRNSInvestee Company Update: Northern Leaf plc
8th Apr 202412:20 pmRNSTransaction in Own Shares & TVR
5th Apr 20248:25 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:34 pmRNSTransaction in Own Shares & TVR
26th Mar 20241:03 pmRNSTransaction in Own Shares
26th Mar 20247:48 amRNSInvestee Company Update: Clean Food Group
25th Mar 20243:40 pmRNSTransaction in Own Shares & TVR
25th Mar 20247:00 amRNSTransaction in Own Shares & TVR
21st Mar 202410:25 amRNSTransaction in Own Shares & TVR
21st Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20242:30 pmRNSInvestee Company Update: Northern Leaf
13th Mar 202412:23 pmRNSTransaction in Own Shares & TVR
12th Mar 202412:19 pmRNSTransaction in Own Shares & TVR
11th Mar 202411:27 amRNSTransaction in Own Shares & TVR
7th Mar 20241:09 pmRNSTransaction in Own Shares
7th Mar 20249:08 amRNSTransaction in Own Shares & TVR
29th Feb 20249:00 amRNSContinuation of Existing Share Buy-Back Programme
20th Feb 20244:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
19th Feb 20247:00 amRNSTransaction in Own Shares & TVR
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares & TVR
8th Feb 20247:00 amRNSTransaction in Own Shares & TVR
7th Feb 20247:00 amRNSTransaction in Own Shares & TVR
5th Feb 20242:00 pmRNSTransaction in Own Shares & TVR
1st Feb 20243:22 pmRNSTransaction in Own Shares & TVR
1st Feb 202410:06 amRNSInvestee Company Update: Little Green Pharma Ltd
26th Jan 20247:00 amRNSTransaction in Own Shares & TVR
25th Jan 20243:03 pmRNSInvestee Company Update: Avextra AG Raises €3.3m
25th Jan 20247:00 amRNSTransaction in Own Shares & TVR
24th Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSTransaction in Own Shares & TVR
22nd Jan 20247:00 amRNSCEO Presenting at Proactive One2One Investor Forum
19th Jan 20246:23 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.